ScholarIQanswers from OpenAlex & ORCID
Barbara Eichhorst
ResearcherPublications, citations & collaboration network
Barbara Eichhorst is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Barbara Eichhorst have?
ScholarIQindexed works
Barbara Eichhorst has 443 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Barbara Eichhorst have?
ScholarIQcitation count
Barbara Eichhorst has 22,209 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Barbara Eichhorst?
ScholarIQh-index
Barbara Eichhorst has an h-index of 63 in OpenAlex.
What is the i10-index of Barbara Eichhorst?
ScholarIQi10-index
Barbara Eichhorst has an i10-index of 190 in OpenAlex.
What is the ORCID of Barbara Eichhorst?
ScholarIQorcid
The ORCID for Barbara Eichhorst is on the source record.
What is the OpenAlex record for Barbara Eichhorst?
ScholarIQopenalex
The OpenAlex for Barbara Eichhorst is on the source record.
What are the most-cited papers on Barbara Eichhorst?
ScholarIQmost cited works
<i>TP53</i> Mutation and Survival in Chronic Lymphocytic Leukemia
Thorsten Zenz, Barbara Eichhorst, Raymonde Busch, Tina Denzel, Sonja Häbe, Dirk Winkler, Andreas Bühler, Jennifer Edelmann, Manuela Bergmann, Georg Hopfinger, Manfred Hensel, Michael Hallek, Hartmut Döhner, Stephan Stilgenbauer
Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group
Kirsten Fischer, Paula Cramer, Raymonde Busch, Sebastian Böttcher, Jasmin Bahlo, Jöerg Schubert, Karl Heinz Pflüger, Silke Schott, Valentin Goede, Susanne Isfort, Julia von Tresckow, Anna‐Maria Fink, Andreas Bühler, Dirk Winkler, Karl‐Anton Kreuzer, Peter Staib, Matthias Ritgen, Michael Kneba, Hartmut Döhner, Barbara Eichhorst, Michael Hallek, Stephan Stilgenbauer, Clemens‐Martin Wendtner
Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group
Kirsten Fischer, Paula Cramer, Raymonde Busch, Stephan Stilgenbauer, Jasmin Bahlo, Carmen D. Schweighofer, Sebastian Böttcher, Peter Staib, Michael Kiehl, Michael J. Eckart, Gabriele Kranz, Valentin Goede, Thomas Elter, Andreas Bühler, Dirk Winkler, Michael Kneba, Hartmut Döhner, Barbara Eichhorst, Michael Hallek, Clemens‐Martin Wendtner